<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01069055</url>
  </required_header>
  <id_info>
    <org_study_id>HerniaAnalgesia2010-001</org_study_id>
    <nct_id>NCT01069055</nct_id>
  </id_info>
  <brief_title>Comparison of Lornoxicam and Paracetamol for Pre-emptive Intravenous Analgesia for Elective Inguinal Hernia Repair</brief_title>
  <official_title>Pre-emptive Intravenous Analgesia for Elective Inguinal Hernia Repair: Prospective Randomized Double-blinded Placebo Controlled Comparison of Lornoxicam and Paracetamol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Diskapi Teaching and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Diskapi Teaching and Research Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether lornoxicam or paracetamol is more effective
      in providing pre-emptive analgesia for adult patients undergoing elective unilateral inguinal
      hernia repair under general anesthesia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Early postoperative pain is the major cause that may restric physical activity of the
      patients and delay in returning work. Newer non-steroid analgesic drugs (NSAD) can be helpful
      in overcoming this problem, especially in pre-emptive use. In this prospective randomized
      placebo controlled double blinded study we aimed to determine whether lornoxicam, as a NSAD,
      or paracetamol is more effective in providing pre-emptive analgesia for patients undergo
      elective unilateral inguinal hernai repair under general anesthesia. 60 patients above the
      age of 18, ASA score of I to III will be assigned into 3 groups. All the patients will be
      operated under general anesthesia. Recurrent hernia cases, pregnant or lactated women,
      patients allergic to the two drugs, patients with documented gastric disorders or bleeding
      disorder or under anticoagulent therapy will be excluded.

      Group designs:

      Group I: 100 ml intravenous saline infusion as placebo 30 minitues before the surgery.

      Group II: 8 mg intravenous lornoxicam infusion in 100 ml saline 30 minitues before the
      surgery.

      Group III: 1 g intravenous paracetamol infusion in 100 ml saline 30 minitues before the
      surgery.

      All patients will receive patient controlled intravenous analgesia with morphine for 24 hours
      postoperatively.

      Postoperative pain levels will be determined by VAS (visual analog scale) and morphine
      consumption will be recorded.

      Patients will be prescribed with oral paracetamol (300 mg) plus codein (15 mg)at discharge at
      the end first 24 hours.

      Patients will be asked to record daily consumption of given analgesic, pain response to
      physical activity by using Likert scale, and VAS scores daily.

      The first follow-up examination will take place on day-7. The patients will be asked to keep
      recording the same parameters until the second hospital visit at 4th week.

      On the follow-up examination at 4th week quality of life will be determined by SF-36 form.

      The results will be analyzed using SPSS for Windows software.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>February 2010</start_date>
  <completion_date type="Anticipated">June 2010</completion_date>
  <primary_completion_date type="Anticipated">June 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative pain and comfort</measure>
    <time_frame>24 and 48 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative late pain complaint and quality of life</measure>
    <time_frame>4. week</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Inguinal Hernia</condition>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Placebo Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Group I (Placebo Control) 100 ml intravenous saline infusion as placebo 30 minitues before the surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lornoxicam</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group II: 8 mg intravenous lornoxicam infusion in 100 ml saline 30 minitues before the surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Paracetamol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group III: 1 g intravenous paracetamol infusion in 100 ml saline 30 minitues before the surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sterile Saline</intervention_name>
    <description>Group I: 100 ml intravenous saline infusion as placebo 30 minitues before the surgery.</description>
    <arm_group_label>Placebo Control</arm_group_label>
    <other_name>Saline</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intravenous lornoxicam</intervention_name>
    <description>Group II: 8 mg intravenous lornoxicam infusion in 100 ml saline 30 minitues before the surgery.</description>
    <arm_group_label>Lornoxicam</arm_group_label>
    <other_name>Lornoxicam: Xefo</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intravenous paracetamol</intervention_name>
    <description>Group III: 1 g intravenous paracetamol infusion in 100 ml saline 30 minitues before the surgery.</description>
    <arm_group_label>Paracetamol</arm_group_label>
    <other_name>Paracetamol: Perfalgan</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  inguinal hernia

          -  unilateral hernia

          -  general anesthesia

          -  elective repair

        Exclusion Criteria:

          -  drug allergy

          -  bilateral hernia

          -  local anesthesia

          -  local blockade

          -  regional anesthesia

          -  emergency surgery

          -  complicated hernia

          -  recurrent hernia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ercan Sonmez, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Diskapi Teaching and Research Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Diskapi Teaching and Research Hospital</name>
      <address>
        <city>Ankara</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alp Alptekin, MD</last_name>
      <phone>+90 312 5962370</phone>
      <email>alptekinmd@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Hakan Kulacoglu, MD, FACS</last_name>
      <email>hakankulacoglu@hotmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>February 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 16, 2010</study_first_submitted>
  <study_first_submitted_qc>February 16, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 17, 2010</study_first_posted>
  <last_update_submitted>February 23, 2010</last_update_submitted>
  <last_update_submitted_qc>February 23, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 24, 2010</last_update_posted>
  <responsible_party>
    <name_title>Diskapi Teaching and Research Hospital</name_title>
    <organization>Ministry of Health</organization>
  </responsible_party>
  <keyword>inguinal hernia</keyword>
  <keyword>surgery</keyword>
  <keyword>general anesthesia</keyword>
  <keyword>analgesia</keyword>
  <keyword>pre-emptive</keyword>
  <keyword>SF36</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Hernia, Inguinal</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Lornoxicam</mesh_term>
    <mesh_term>Piroxicam</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

